GLP-1 receptor agonists have emerged as a major advancement, offering clinically meaningful and sustained weight loss alongside improvements in glycemic control and cardiovascular outcomes
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
FIGURE 11 3.12 Histopathological scoring results Figure 12 shows a descriptive analysis of various histopathological changes, illustrating the negative effects of an HFD and the positive effects of gliben, exercise, and IF
Documentation rules can also vary
COA, HPLC, and MS documents support identity, purity, and batch-record review
Hamilton Depression Rating Scale (HDRS), 23 Beck Depression Inventory (BDI), 24 and Montgomerysberg Depression Rating Scale (MADRS) 25 as standardized mean differences (SMDs) and their corresponding 95% CI at end-of-treatment (negative values favor ALC) using random-effects (REML) models